ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Stem Cell Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-24D5802
Home | Market Reports | Health| Health Foundations & Medical Research
Global Cancer Stem Cell Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Cancer Stem Cell Market Insights, Forecast to 2029

Code: QYRE-Auto-24D5802
Report
August 2023
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific Inc
AbbVie
Merck KGaA
Bionomics Ltd
Lonza
Stemline Therapeutics Inc
Miltenyi Biotec
PromoCell
MacroGenics Inc
OncoMed Pharmaceuticals Inc
Irvine Scientific
Stemcell Technologies Inc
Sino Biological Inc
BioTime

Cancer Stem Cell Market Size

The global Cancer Stem Cell market is projected to grow from US$ 1147 million in 2023 to US$ 1781.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.6% during the forecast period.

Cancer Stem Cell Market

Cancer Stem Cell Market

Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.
Market Analysis and Insights: Global Cancer Stem Cell Market
North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.
Report Includes
This report presents an overview of global market for Cancer Stem Cell market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Cancer Stem Cell, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Stem Cell, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Stem Cell revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Cancer Stem Cell market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Cancer Stem Cell revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Inc., AbbVie, Inc., Merck KGaA, Bionomics, Lonza, Stemline Therapeutics, Inc., Miltenyi Biotec, PromoCell GmbH and MacroGenics, Inc., etc.

Scope of Cancer Stem Cell Market Report

Report Metric Details
Report Name Cancer Stem Cell Market
Accounted market size in 2023 US$ 1147 million
Forecasted market size in 2029 US$ 1781.1 million
CAGR 7.6
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Cell Culturing
  • Cell Separation
  • Cell Analysis
  • Molecular Analysis
  • Others
Segment by Application
  • Stem Cell Based Cancer Therapy
  • Targeted CSCs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Inc., AbbVie, Inc., Merck KGaA, Bionomics, Lonza, Stemline Therapeutics, Inc., Miltenyi Biotec, PromoCell GmbH, MacroGenics, Inc., OncoMed Pharmaceuticals, Inc., Irvine Scientific, STEMCELL Technologies Inc., Sino Biological Inc., BIOTIME, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Cancer Stem Cell in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Stem Cell companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Stem Cell revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Cancer Stem Cell Market growing?

Ans: The Cancer Stem Cell Market witnessing a CAGR of 7.6 during the forecast period 2023-2029.

What is the Cancer Stem Cell Market size in 2029?

Ans: The global Cancer Stem Cell market is projected to grow from US$ 1147 million in 2023 to US$ 1781.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.6% during the forecast period.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Stem Cell Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cell Culturing
1.2.3 Cell Separation
1.2.4 Cell Analysis
1.2.5 Molecular Analysis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Stem Cell Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Stem Cell Based Cancer Therapy
1.3.3 Targeted CSCs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Stem Cell Market Perspective (2018-2029)
2.2 Global Cancer Stem Cell Growth Trends by Region
2.2.1 Cancer Stem Cell Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Stem Cell Historic Market Size by Region (2018-2023)
2.2.3 Cancer Stem Cell Forecasted Market Size by Region (2024-2029)
2.3 Cancer Stem Cell Market Dynamics
2.3.1 Cancer Stem Cell Industry Trends
2.3.2 Cancer Stem Cell Market Drivers
2.3.3 Cancer Stem Cell Market Challenges
2.3.4 Cancer Stem Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer Stem Cell by Players
3.1.1 Global Cancer Stem Cell Revenue by Players (2018-2023)
3.1.2 Global Cancer Stem Cell Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Stem Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Stem Cell, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cancer Stem Cell Market Concentration Ratio
3.4.1 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Stem Cell Revenue in 2022
3.5 Global Key Players of Cancer Stem Cell Head office and Area Served
3.6 Global Key Players of Cancer Stem Cell, Product and Application
3.7 Global Key Players of Cancer Stem Cell, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Stem Cell Breakdown Data by Type
4.1 Global Cancer Stem Cell Historic Market Size by Type (2018-2023)
4.2 Global Cancer Stem Cell Forecasted Market Size by Type (2024-2029)
5 Cancer Stem Cell Breakdown Data by Application
5.1 Global Cancer Stem Cell Historic Market Size by Application (2018-2023)
5.2 Global Cancer Stem Cell Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cancer Stem Cell Market Size (2018-2029)
6.2 North America Cancer Stem Cell Market Size by Type
6.2.1 North America Cancer Stem Cell Market Size by Type (2018-2023)
6.2.2 North America Cancer Stem Cell Market Size by Type (2024-2029)
6.2.3 North America Cancer Stem Cell Market Share by Type (2018-2029)
6.3 North America Cancer Stem Cell Market Size by Application
6.3.1 North America Cancer Stem Cell Market Size by Application (2018-2023)
6.3.2 North America Cancer Stem Cell Market Size by Application (2024-2029)
6.3.3 North America Cancer Stem Cell Market Share by Application (2018-2029)
6.4 North America Cancer Stem Cell Market Size by Country
6.4.1 North America Cancer Stem Cell Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Cancer Stem Cell Market Size by Country (2018-2023)
6.4.3 North America Cancer Stem Cell Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cancer Stem Cell Market Size (2018-2029)
7.2 Europe Cancer Stem Cell Market Size by Type
7.2.1 Europe Cancer Stem Cell Market Size by Type (2018-2023)
7.2.2 Europe Cancer Stem Cell Market Size by Type (2024-2029)
7.2.3 Europe Cancer Stem Cell Market Share by Type (2018-2029)
7.3 Europe Cancer Stem Cell Market Size by Application
7.3.1 Europe Cancer Stem Cell Market Size by Application (2018-2023)
7.3.2 Europe Cancer Stem Cell Market Size by Application (2024-2029)
7.3.3 Europe Cancer Stem Cell Market Share by Application (2018-2029)
7.4 Europe Cancer Stem Cell Market Size by Country
7.4.1 Europe Cancer Stem Cell Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Cancer Stem Cell Market Size by Country (2018-2023)
7.4.3 Europe Cancer Stem Cell Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer Stem Cell Market Size (2018-2029)
8.2 China Cancer Stem Cell Market Size by Type
8.2.1 China Cancer Stem Cell Market Size by Type (2018-2023)
8.2.2 China Cancer Stem Cell Market Size by Type (2024-2029)
8.2.3 China Cancer Stem Cell Market Share by Type (2018-2029)
8.3 China Cancer Stem Cell Market Size by Application
8.3.1 China Cancer Stem Cell Market Size by Application (2018-2023)
8.3.2 China Cancer Stem Cell Market Size by Application (2024-2029)
8.3.3 China Cancer Stem Cell Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cancer Stem Cell Market Size (2018-2029)
9.2 Asia Cancer Stem Cell Market Size by Type
9.2.1 Asia Cancer Stem Cell Market Size by Type (2018-2023)
9.2.2 Asia Cancer Stem Cell Market Size by Type (2024-2029)
9.2.3 Asia Cancer Stem Cell Market Share by Type (2018-2029)
9.3 Asia Cancer Stem Cell Market Size by Application
9.3.1 Asia Cancer Stem Cell Market Size by Application (2018-2023)
9.3.2 Asia Cancer Stem Cell Market Size by Application (2024-2029)
9.3.3 Asia Cancer Stem Cell Market Share by Application (2018-2029)
9.4 Asia Cancer Stem Cell Market Size by Region
9.4.1 Asia Cancer Stem Cell Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Cancer Stem Cell Market Size by Region (2018-2023)
9.4.3 Asia Cancer Stem Cell Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer Stem Cell Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Cancer Stem Cell Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Cancer Stem Cell Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2018-2023)
11.1.5 Thermo Fisher Scientific, Inc. Recent Developments
11.2 AbbVie, Inc.
11.2.1 AbbVie, Inc. Company Details
11.2.2 AbbVie, Inc. Business Overview
11.2.3 AbbVie, Inc. Cancer Stem Cell Introduction
11.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2018-2023)
11.2.5 AbbVie, Inc. Recent Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Cancer Stem Cell Introduction
11.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2018-2023)
11.3.5 Merck KGaA Recent Developments
11.4 Bionomics
11.4.1 Bionomics Company Details
11.4.2 Bionomics Business Overview
11.4.3 Bionomics Cancer Stem Cell Introduction
11.4.4 Bionomics Revenue in Cancer Stem Cell Business (2018-2023)
11.4.5 Bionomics Recent Developments
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Cancer Stem Cell Introduction
11.5.4 Lonza Revenue in Cancer Stem Cell Business (2018-2023)
11.5.5 Lonza Recent Developments
11.6 Stemline Therapeutics, Inc.
11.6.1 Stemline Therapeutics, Inc. Company Details
11.6.2 Stemline Therapeutics, Inc. Business Overview
11.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Introduction
11.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2018-2023)
11.6.5 Stemline Therapeutics, Inc. Recent Developments
11.7 Miltenyi Biotec
11.7.1 Miltenyi Biotec Company Details
11.7.2 Miltenyi Biotec Business Overview
11.7.3 Miltenyi Biotec Cancer Stem Cell Introduction
11.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2018-2023)
11.7.5 Miltenyi Biotec Recent Developments
11.8 PromoCell GmbH
11.8.1 PromoCell GmbH Company Details
11.8.2 PromoCell GmbH Business Overview
11.8.3 PromoCell GmbH Cancer Stem Cell Introduction
11.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2018-2023)
11.8.5 PromoCell GmbH Recent Developments
11.9 MacroGenics, Inc.
11.9.1 MacroGenics, Inc. Company Details
11.9.2 MacroGenics, Inc. Business Overview
11.9.3 MacroGenics, Inc. Cancer Stem Cell Introduction
11.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2018-2023)
11.9.5 MacroGenics, Inc. Recent Developments
11.10 OncoMed Pharmaceuticals, Inc.
11.10.1 OncoMed Pharmaceuticals, Inc. Company Details
11.10.2 OncoMed Pharmaceuticals, Inc. Business Overview
11.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Introduction
11.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2018-2023)
11.10.5 OncoMed Pharmaceuticals, Inc. Recent Developments
11.11 Irvine Scientific
11.11.1 Irvine Scientific Company Details
11.11.2 Irvine Scientific Business Overview
11.11.3 Irvine Scientific Cancer Stem Cell Introduction
11.11.4 Irvine Scientific Revenue in Cancer Stem Cell Business (2018-2023)
11.11.5 Irvine Scientific Recent Developments
11.12 STEMCELL Technologies Inc.
11.12.1 STEMCELL Technologies Inc. Company Details
11.12.2 STEMCELL Technologies Inc. Business Overview
11.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Introduction
11.12.4 STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2018-2023)
11.12.5 STEMCELL Technologies Inc. Recent Developments
11.13 Sino Biological Inc.
11.13.1 Sino Biological Inc. Company Details
11.13.2 Sino Biological Inc. Business Overview
11.13.3 Sino Biological Inc. Cancer Stem Cell Introduction
11.13.4 Sino Biological Inc. Revenue in Cancer Stem Cell Business (2018-2023)
11.13.5 Sino Biological Inc. Recent Developments
11.14 BIOTIME, Inc.
11.14.1 BIOTIME, Inc. Company Details
11.14.2 BIOTIME, Inc. Business Overview
11.14.3 BIOTIME, Inc. Cancer Stem Cell Introduction
11.14.4 BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2018-2023)
11.14.5 BIOTIME, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Thermo Fisher Scientific Inc
AbbVie
Merck KGaA
Bionomics Ltd
Lonza
Stemline Therapeutics Inc
Miltenyi Biotec
PromoCell
MacroGenics Inc
OncoMed Pharmaceuticals Inc
Irvine Scientific
Stemcell Technologies Inc
Sino Biological Inc
BioTime
List of Tables
    Table 1. Global Cancer Stem Cell Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Cell Culturing
    Table 3. Key Players of Cell Separation
    Table 4. Key Players of Cell Analysis
    Table 5. Key Players of Molecular Analysis
    Table 6. Key Players of Others
    Table 7. Global Cancer Stem Cell Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 8. Global Cancer Stem Cell Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Cancer Stem Cell Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Cancer Stem Cell Market Share by Region (2018-2023)
    Table 11. Global Cancer Stem Cell Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Cancer Stem Cell Market Share by Region (2024-2029)
    Table 13. Cancer Stem Cell Market Trends
    Table 14. Cancer Stem Cell Market Drivers
    Table 15. Cancer Stem Cell Market Challenges
    Table 16. Cancer Stem Cell Market Restraints
    Table 17. Global Cancer Stem Cell Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Cancer Stem Cell Revenue Share by Players (2018-2023)
    Table 19. Global Top Cancer Stem Cell by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Stem Cell as of 2022)
    Table 20. Global Cancer Stem Cell Industry Ranking 2021 VS 2022 VS 2023
    Table 21. Global 5 Largest Players Market Share by Cancer Stem Cell Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Global Key Players of Cancer Stem Cell, Headquarters and Area Served
    Table 23. Global Key Players of Cancer Stem Cell, Product and Application
    Table 24. Global Key Players of Cancer Stem Cell, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Cancer Stem Cell Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Cancer Stem Cell Revenue Market Share by Type (2018-2023)
    Table 28. Global Cancer Stem Cell Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Cancer Stem Cell Revenue Market Share by Type (2024-2029)
    Table 30. Global Cancer Stem Cell Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Cancer Stem Cell Revenue Share by Application (2018-2023)
    Table 32. Global Cancer Stem Cell Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Cancer Stem Cell Revenue Share by Application (2024-2029)
    Table 34. North America Cancer Stem Cell Market Size by Type (2018-2023) & (US$ Million)
    Table 35. North America Cancer Stem Cell Market Size by Type (2024-2029) & (US$ Million)
    Table 36. North America Cancer Stem Cell Market Size by Application (2018-2023) & (US$ Million)
    Table 37. North America Cancer Stem Cell Market Size by Application (2024-2029) & (US$ Million)
    Table 38. North America Cancer Stem Cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. North America Cancer Stem Cell Market Size by Country (2018-2023) & (US$ Million)
    Table 40. North America Cancer Stem Cell Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Europe Cancer Stem Cell Market Size by Type (2018-2023) & (US$ Million)
    Table 42. Europe Cancer Stem Cell Market Size by Type (2024-2029) & (US$ Million)
    Table 43. Europe Cancer Stem Cell Market Size by Application (2018-2023) & (US$ Million)
    Table 44. Europe Cancer Stem Cell Market Size by Application (2024-2029) & (US$ Million)
    Table 45. Europe Cancer Stem Cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Europe Cancer Stem Cell Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Europe Cancer Stem Cell Market Size by Country (2024-2029) & (US$ Million)
    Table 48. China Cancer Stem Cell Market Size by Type (2018-2023) & (US$ Million)
    Table 49. China Cancer Stem Cell Market Size by Type (2024-2029) & (US$ Million)
    Table 50. China Cancer Stem Cell Market Size by Application (2018-2023) & (US$ Million)
    Table 51. China Cancer Stem Cell Market Size by Application (2024-2029) & (US$ Million)
    Table 52. Asia Cancer Stem Cell Market Size by Type (2018-2023) & (US$ Million)
    Table 53. Asia Cancer Stem Cell Market Size by Type (2024-2029) & (US$ Million)
    Table 54. Asia Cancer Stem Cell Market Size by Application (2018-2023) & (US$ Million)
    Table 55. Asia Cancer Stem Cell Market Size by Application (2024-2029) & (US$ Million)
    Table 56. Asia Cancer Stem Cell Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 57. Asia Cancer Stem Cell Market Size by Region (2018-2023) & (US$ Million)
    Table 58. Asia Cancer Stem Cell Market Size by Region (2024-2029) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Type (2018-2023) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Type (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Application (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Application (2024-2029) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Cancer Stem Cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 64. Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Country (2018-2023) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Cancer Stem Cell Market Size by Country (2024-2029) & (US$ Million)
    Table 66. Thermo Fisher Scientific, Inc. Company Details
    Table 67. Thermo Fisher Scientific, Inc. Business Overview
    Table 68. Thermo Fisher Scientific, Inc. Cancer Stem Cell Product
    Table 69. Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 70. Thermo Fisher Scientific, Inc. Recent Developments
    Table 71. AbbVie, Inc. Company Details
    Table 72. AbbVie, Inc. Business Overview
    Table 73. AbbVie, Inc. Cancer Stem Cell Product
    Table 74. AbbVie, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 75. AbbVie, Inc. Recent Developments
    Table 76. Merck KGaA Company Details
    Table 77. Merck KGaA Business Overview
    Table 78. Merck KGaA Cancer Stem Cell Product
    Table 79. Merck KGaA Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 80. Merck KGaA Recent Developments
    Table 81. Bionomics Company Details
    Table 82. Bionomics Business Overview
    Table 83. Bionomics Cancer Stem Cell Product
    Table 84. Bionomics Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 85. Bionomics Recent Developments
    Table 86. Lonza Company Details
    Table 87. Lonza Business Overview
    Table 88. Lonza Cancer Stem Cell Product
    Table 89. Lonza Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 90. Lonza Recent Developments
    Table 91. Stemline Therapeutics, Inc. Company Details
    Table 92. Stemline Therapeutics, Inc. Business Overview
    Table 93. Stemline Therapeutics, Inc. Cancer Stem Cell Product
    Table 94. Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 95. Stemline Therapeutics, Inc. Recent Developments
    Table 96. Miltenyi Biotec Company Details
    Table 97. Miltenyi Biotec Business Overview
    Table 98. Miltenyi Biotec Cancer Stem Cell Product
    Table 99. Miltenyi Biotec Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 100. Miltenyi Biotec Recent Developments
    Table 101. PromoCell GmbH Company Details
    Table 102. PromoCell GmbH Business Overview
    Table 103. PromoCell GmbH Cancer Stem Cell Product
    Table 104. PromoCell GmbH Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 105. PromoCell GmbH Recent Developments
    Table 106. MacroGenics, Inc. Company Details
    Table 107. MacroGenics, Inc. Business Overview
    Table 108. MacroGenics, Inc. Cancer Stem Cell Product
    Table 109. MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 110. MacroGenics, Inc. Recent Developments
    Table 111. OncoMed Pharmaceuticals, Inc. Company Details
    Table 112. OncoMed Pharmaceuticals, Inc. Business Overview
    Table 113. OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Product
    Table 114. OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 115. OncoMed Pharmaceuticals, Inc. Recent Developments
    Table 116. Irvine Scientific Company Details
    Table 117. Irvine Scientific Business Overview
    Table 118. Irvine Scientific Cancer Stem Cell Product
    Table 119. Irvine Scientific Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 120. Irvine Scientific Recent Developments
    Table 121. STEMCELL Technologies Inc. Company Details
    Table 122. STEMCELL Technologies Inc. Business Overview
    Table 123. STEMCELL Technologies Inc. Cancer Stem Cell Product
    Table 124. STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 125. STEMCELL Technologies Inc. Recent Developments
    Table 126. Sino Biological Inc. Company Details
    Table 127. Sino Biological Inc. Business Overview
    Table 128. Sino Biological Inc. Cancer Stem Cell Product
    Table 129. Sino Biological Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 130. Sino Biological Inc. Recent Developments
    Table 131. BIOTIME, Inc. Company Details
    Table 132. BIOTIME, Inc. Business Overview
    Table 133. BIOTIME, Inc. Cancer Stem Cell Product
    Table 134. BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million)
    Table 135. BIOTIME, Inc. Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Stem Cell Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Cancer Stem Cell Market Share by Type: 2022 VS 2029
    Figure 3. Cell Culturing Features
    Figure 4. Cell Separation Features
    Figure 5. Cell Analysis Features
    Figure 6. Molecular Analysis Features
    Figure 7. Others Features
    Figure 8. Global Cancer Stem Cell Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 9. Global Cancer Stem Cell Market Share by Application: 2022 VS 2029
    Figure 10. Stem Cell Based Cancer Therapy Case Studies
    Figure 11. Targeted CSCs Case Studies
    Figure 12. Cancer Stem Cell Report Years Considered
    Figure 13. Global Cancer Stem Cell Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Cancer Stem Cell Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Cancer Stem Cell Market Share by Region: 2022 VS 2029
    Figure 16. Global Cancer Stem Cell Market Share by Players in 2022
    Figure 17. Global Top Cancer Stem Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Stem Cell as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Cancer Stem Cell Revenue in 2022
    Figure 19. North America Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Cancer Stem Cell Market Share by Type (2018-2029)
    Figure 21. North America Cancer Stem Cell Market Share by Application (2018-2029)
    Figure 22. North America Cancer Stem Cell Market Share by Country (2018-2029)
    Figure 23. United States Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Cancer Stem Cell Market Size YoY (2018-2029) & (US$ Million)
    Figure 26. Europe Cancer Stem Cell Market Share by Type (2018-2029)
    Figure 27. Europe Cancer Stem Cell Market Share by Application (2018-2029)
    Figure 28. Europe Cancer Stem Cell Market Share by Country (2018-2029)
    Figure 29. Germany Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. France Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. U.K. Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Italy Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Russia Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Nordic Countries Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. China Cancer Stem Cell Market Size YoY (2018-2029) & (US$ Million)
    Figure 36. China Cancer Stem Cell Market Share by Type (2018-2029)
    Figure 37. China Cancer Stem Cell Market Share by Application (2018-2029)
    Figure 38. Asia Cancer Stem Cell Market Size YoY (2018-2029) & (US$ Million)
    Figure 39. Asia Cancer Stem Cell Market Share by Type (2018-2029)
    Figure 40. Asia Cancer Stem Cell Market Share by Application (2018-2029)
    Figure 41. Asia Cancer Stem Cell Market Share by Region (2018-2029)
    Figure 42. Japan Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. South Korea Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. China Taiwan Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Southeast Asia Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. India Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Australia Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Cancer Stem Cell Market Size YoY (2018-2029) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Cancer Stem Cell Market Share by Type (2018-2029)
    Figure 50. Middle East, Africa, and Latin America Cancer Stem Cell Market Share by Application (2018-2029)
    Figure 51. Middle East, Africa, and Latin America Cancer Stem Cell Market Share by Country (2018-2029)
    Figure 52. Brazil Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Mexico Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Turkey Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Israel Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. GCC Countries Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 59. AbbVie, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 60. Merck KGaA Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 61. Bionomics Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 62. Lonza Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 63. Stemline Therapeutics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 64. Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 65. PromoCell GmbH Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 66. MacroGenics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 67. OncoMed Pharmaceuticals, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 68. Irvine Scientific Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 69. STEMCELL Technologies Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 70. Sino Biological Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 71. BIOTIME, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions